Affymetrix Incorporated is a medical analysis company, dedicating their time to making tools to analysis protein and cellular study. The company pulled out a surprising profit this quarter, with strong product sales and lower prices. Affymetrix is forecasting a profitable year in 2010. The company’s revenue for the quarter rose 13 percent, and product revenue increased 22 percent. Their net income recorded Wednesday, February 3rd, was about $2.8 million, or 4 cents a share, compared to a loss in the same quarter last year, of $318.7 million, or $4.65 a share. This came as a surprise to analysts who thought that Afffymetrix would lose 10 cents a share.
